Luna Labs USA, LLC (“Luna Labs” or “Luna”) has announced the divestiture of its TrueClot and Dislotech product lines to Integrated MedCraft, LLC, marking another milestone in Luna’s commercialization efforts.
Since its inception at Luna Labs, TrueClot has been an innovator in bleeding control training. Developed through early SBIR-funded research, TrueClot introduced a patented blood simulant technology that elevated trauma education by providing realistic clotting behavior for wound packing and tourniquet application. Over the years, Luna Labs expanded the TrueClot product line to include advanced task trainers and simulation kits, which were distributed globally to a loyal customer base of military medics, EMS professionals, and other first responders.
Meanwhile, the Dislotech product line focuses on anatomically accurate Joint Reduction Trainers (JRTs) designed for teaching proper reduction techniques of dislocated joints. The portfolio includes two core families—the Shoulder JRT and Finger JRT—each enabling hands-on simulation of joint dislocations and reductions.
This transaction provides a debt-free balance sheet for Luna and liquidity to its investors. Luna will continue to prioritize technology monetization through a robust commercialization framework which will drive repeatable pathways for value creation. Combining Luna’s leading contract research business with its commercialization initiatives position Luna as a trusted partner for government agencies and Fortune 500 companies seeking advanced solutions in the defense and healthcare.
We congratulate the Luna management team on a significant achievement.